Search results for: 'ride rare'

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

23 Sep 2019  |  South Asia, Middle East & North Africa  |  Market Research

Strategic Assessment of Shared Mobility Market in India, 2019

The Indian Shared Mobility Market Comprises More than 2 Million Vehicles. With Growing Acceptance, It is Expected to Grow at a CAGR of 9.7% Until 2025

Infographics

×

Key Issues Addressed Key Benefits

The aim of this study is to evaluate the shared mobility market in India and differentiate the various business models available. The study focuses on investment, growth opportunities, and partnerships within the automotive industry. It also analyses the strategies of the main shared mobility companies in India. Total shared mobility fleet in India...

The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

Intelligent Mobility Japan, 2020 is a virtual summit organized by Frost & Sullivan on November 24 and 25, 2020. This is a 2-day interactive conference, which hosted on a unique virtual platform to discuss and evaluate Growth Opportunities in new Mobility Business models covering Personal and Public Transport Systems. The conference presenters inc...

Advanced suspension systems were touted to be the next big thing in the automotive industry when they were launched a couple of decades ago. However, owing to the high cost of these systems, their market penetration has remained confined to premium vehicles. Many original equipment manufacturers (OEMs) have been offering passive suspension systems ...

By 2030, the shared mobility market will have 10.5 million electric vehicles in its fleet dominated by electric bikes and then ride-hailing vehicles. Electrification was under the radar of all the mobility operators and cities, even before the pandemic. Cities should neither lose sight of the long-term goal which is to reduce GHG emissions nor brea...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...